248 related articles for article (PubMed ID: 10464888)
21. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF; Buist AS
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[TBL] [Abstract][Full Text] [Related]
22. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L
J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526
[TBL] [Abstract][Full Text] [Related]
23. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
24. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
Harrison LI
J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
[TBL] [Abstract][Full Text] [Related]
25. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
Micheletto C; Guerriero M; Tognella S; Dal Negro RW
Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
[TBL] [Abstract][Full Text] [Related]
26. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
Magnussen H
Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
[TBL] [Abstract][Full Text] [Related]
27. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
28. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
Bousquet J; Cantini L
Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
[TBL] [Abstract][Full Text] [Related]
29. Equivalent asthma control and systemic safety of inhaled budesonide delivered via HFA-134a or CFC propellant in a broad range of doses.
Grzelewska-Rzymowska I; Malolepszy J; de Molina M; Sladek K; Zarkovice J; Siergiejko Z;
Respir Med; 2003 Nov; 97 Suppl D():S10-9. PubMed ID: 14753247
[TBL] [Abstract][Full Text] [Related]
30. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
Seale JP; Harrison LI
Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
[TBL] [Abstract][Full Text] [Related]
31. Inhaled beclomethasone versus placebo for chronic asthma.
Adams NP; Bestall JB; Malouf R; Lasserson TJ; Jones PW
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD002738. PubMed ID: 15674896
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
[TBL] [Abstract][Full Text] [Related]
33. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA-134a) is equivalent to BDP-CFC for the treatment of asthma: Milanowski et al. (Respir Med 1999; 93: 245-251).
Ayres JG
Respir Med; 2000 Feb; 94(2):181-2; author reply 183. PubMed ID: 10714430
[No Abstract] [Full Text] [Related]
34. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
Perruchoud AP; Lundback B; Yigla M; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
[TBL] [Abstract][Full Text] [Related]
36. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
Leach CL; Colice GL
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.
Matthys H; Nowak D; Hader S; Kunkel G
Respir Med; 1998 Jun; 92 Suppl A():17-22. PubMed ID: 9850359
[TBL] [Abstract][Full Text] [Related]
38. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[TBL] [Abstract][Full Text] [Related]
39. Modulite technology: pharmacodynamic and pharmacokinetic implications.
Woodcock A; Acerbi D; Poli G
Respir Med; 2002 Aug; 96 Suppl D():S9-15. PubMed ID: 12201080
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
Rony F; Cortellini M; Guasconi A; Mathews KS; Piccinno A; Poli G; Vanhoutte F; Klein J
Pulm Pharmacol Ther; 2024 Jun; 85():102299. PubMed ID: 38663512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
